Catalent
The Pharmaceutical Development Principal Scientist I at Catalent's Kansas City facility will provide technical expertise and support for oral solid dosage development programs, author key technical documents, and lead project teams. The role involves troubleshooting, risk assessments, and contributing to strategic initiatives while collaborating closely with clients and internal stakeholders.
Headquarters
Tampa, Florida, United States
Company Size
10001+ employees
Founded
2007
Catalent delivers end-to-end pharma solutions as a trusted CDMO, advancing drug development and manufacturing worldwide. Partner with us today!
Novo's troubled Indiana plant claims another victim as FDA rejects Incyte's lung cancer application
3 days ago
Inspection issues remain at Catalent Indiana plant, pharma companies say
1 day ago
Incyte’s Lung Cancer Expansion Bid Thwarted by Issues at Novo’s Catalent-Acquired Site
3 days ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Catalent.
Catalent didn’t post a salary, so this is our estimate from similar listings.
Catalent to lay off at least 96 employees in Maryland amid ongoing workforce reductions
3 weeks ago
Sr. Scientist
Arcus Biosciences
Scientist III, Material & Analytical Sciences
Digital Biology
Process Development Technician
Global Channel Management
Scientist I, Material and Analytical Sciences
Digital Biology
Solutions Engineer
GEA Group
Process Operator - Pharmaceutical Production - Fixed Term 12 Month
Piramal Pharma Solutions